Does PTCY increase the risk of infections?

M Mikulska, C Bartalucci, AM Raiola, C Oltolini - Blood Reviews, 2023 - Elsevier
PTCY has been mainly used in haploidentical transplant (haploHSCT), but its use in
matched donors allowed better evaluation of infectious risk conferred separately by PTCY or …

[HTML][HTML] High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies

G Mori, S Diotallevi, F Farina, R Lolatto, L Galli… - Microorganisms, 2024 - mdpi.com
Invasive fungal diseases (IFDs) still represent a relevant cause of mortality in patients
affected by hematological malignancies, especially acute myeloid leukaemia (AML) and …

Incidence and impact of fungal infections in post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical hematopoietic …

GA Papanicolaou, M Chen, N He, MJ Martens… - … and Cellular Therapy, 2024 - Elsevier
Fungal infection (FI) after allogeneic hematopoietic cell transplantation (HCT) is associated
with increased morbidity and mortality. Neutropenia, HLA mismatch, graft-versus-host …

Risk factors for invasive fungal infections after hematopoietic stem cell transplantation: a systematic review and meta-analysis

L Biyun, H Yahui, L Yuanfang, G Xifeng… - Clinical Microbiology and …, 2024 - Elsevier
Abstract Background Invasive fungal infections (IFIs) are a common infectious complications
after hematopoietic stem cell transplantation (HSCT), seriously threatening the survival of …

[HTML][HTML] Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD

X Chen, X Zheng, N Lu, R Zhang, W Zhai, Q Ma… - International …, 2023 - Elsevier
Objective Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a
serious life-threatening complication. The granulocyte colony-stimulated factor mobilized …

Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft

JS Little, R Duléry, RM Shapiro, MM Aleissa… - … and Cellular Therapy, 2024 - Elsevier
Post-transplantation cyclophosphamide (PTCy) is an effective strategy for graft-versus-host
disease (GVHD) prophylaxis and is the standard of care for haploidentical hematopoietic …

Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse

RM Shapiro, HT Kim, M Ansuinelli, I Guleria… - Blood …, 2023 - ashpublications.org
Cytokine release syndrome (CRS) following haploidentical hematopoietic cell
transplantation (HCT) resembles CRS after chimeric antigen receptor-T therapy. We …